Success Story: Turning Cardiac Data into Better Clinical Decisions Leads to NIW Approval
Client’s Testimonial:
"Thank you so much!"
On May 21st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Statistician Associate in the Field of Biostatistics (Approval Notice).
General Field: Biostatistics
Position at the Time of Case Filing: Statistician Associate
Country of Origin: China
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: May 21st, 2026
Processing Time: 2 months, 16 days (Premium Processing Requested)
Case Summary:
In cardiovascular care, the right data analysis can help physicians identify which patients face the highest risks and which treatments may offer the best outcomes. This NIW case centered on that exact need.
North America Immigration Law Group (Chen Immigration Law Associates) represented a statistician associate from China whose work in biostatistics focused on improving how cardiac illness severity, treatment effectiveness, and patient outcomes are evaluated. The client held an M.A. in biostatistics, with specialized experience in statistical modeling, clinical data analysis, data management, and biomedical research.
The petition presented her proposed endeavor as a contribution to evidence-based cardiovascular care. Her work focused on advanced statistical and clinical analyses designed to identify effective combinations of cardiology devices and pharmacological treatments, reduce mortality among cardiac patients, and build more accurate systems for assessing severe cardiac illness.
The strength of the case came from showing how her statistical work had already influenced cardiovascular research. Her record included 10 peer-reviewed journal articles and 719 citations. Several of her papers ranked among the most-cited articles for their publication years, including 6 in the top 1%, 6 in the top 10%, and 3 in the top 20%.
NAILG also highlighted examples of independent reliance on her work. Later studies used her research on cardiogenic shock staging, heart failure trajectories, and sex-based outcome differences to support further work on shock severity assessment, predictive modeling, and mortality disparities. This helped demonstrate that her analyses were already shaping how researchers assess complex cardiovascular patient populations.
We are proud to have assisted this client in securing NIW approval and supporting her continued contributions to biostatistics and cardiovascular outcomes research in the United States.